Indapamide Sandoz

Indapamide, the active ingredient in Indapamide Sandoz, is a thiazide-like diuretic presented as an oral tablet for oral use. It treats hypertension and edema associated with heart failure, renal or hepatic disease. GNH USA supplies Indapamide Sandoz as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide is a thiazide‑like diuretic that acts on fluid balance and vascular resistance, helping manage several cardiovascular and renal conditions. - Hypertension: lowers blood pressure by reducing plasma volume and peripheral resistance. - Congestive heart failure‑related edema: decreases fluid accumulation, improving symptoms. - Renal disease‑associated edema: promotes diuresis to reduce swelling. - Hepatic disease‑associated edema: helps remove excess fluid in cirrhosis‑related ascites.

Indapamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Electrolyte disturbances (e.g., low potassium) - Increased urination - Dizziness or light‑headedness - Headache

Serious or Rare Side Effects: - Severe dehydration - Acute kidney injury - Hyponatremia with neurological signs - Allergic reactions such as rash or angioedema

When prescribing Indapamide, clinicians should consider several safety aspects. - Renal function: assess baseline kidney function and monitor periodically. - Electrolytes: check serum potassium and sodium before initiation and during therapy. - Diabetes: monitor blood glucose as diuretics may affect glycemic control. - Gout: use cautiously in patients with a history of gout attacks. - Pregnancy and lactation: avoid unless benefits outweigh potential risks. - Store at room temperature: keep in original container, protect from moisture and light.

Indapamide can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Lithium: increased lithium levels may cause toxicity. - NSAIDs: may reduce diuretic effect and worsen renal function. - ACE inhibitors or ARBs: combined use can lead to significant potassium loss and hypotension.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: risk of hypoglycemia may increase. - Other antihypertensives: additive blood pressure lowering effect. - Corticosteroids: may enhance sodium loss.